InsidersTradesSigma
카나프테라퓨틱스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 카나프테라퓨틱스 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 카나프테라퓨틱스 has published 18 reports. Market capitalisation: €252.9bn. The latest transaction was filed on 22 May 2026 (Other). Among the most active insiders: 김동건. All data is openly available.
18
Insider Decl.
0
Thresholds
€334,253
13 ops.
Buy Volume
·
1 ops.
Sell Volume
30Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 May 2026
Declarations18 total
752,163 sharesKRXDART:20260323000331
Ideal exit: 11 Dec 2026 (T+270)
5,013,135 sharesKRXDART:20260317000652
Ideal exit: 11 Dec 2026 (T+270)
ShareKRXDART:20260317000615
Ideal exit: 12 Dec 2026 (T+270)
18 of 18 declarations